Effective March 17, 2025, The U.S. subsidiary of BeiGene, Ltd. has changed its name to BeOne Medicines USA, Inc. This change comes ahead of our anticipated global rebranding to BeOne Medicines Ltd. and redomiciliation to Switzerland, pending shareholder approval. The new name reflects our commitment to develop innovative medicines and partner with the global community to help as many patients with cancer as possible. To learn more about BeOne Medicines, please follow our new LinkedIn profile @BeOne Medicines.
Looking for a particular BeiGene employee's phone or email?
BeiGene Questions
The BeiGene annual revenue was $877 million in 2026.
John Oyler is the Founder and CEO of BeiGene.
1,499 people are employed at BeiGene.
BeiGene is based in Cambridge, Massachusetts.
The NAICS codes for BeiGene are [54199, 541, 5419, 32, 54, 325, 541990].
The SIC codes for BeiGene are [729, 873, 87, 72].
Top BeiGene Employees
-
John Oyler
Founder and CEO at BeiGene
United States24 -
Minmin Wang
CSO, BeiGene Guangzhou Innovation Center at BeiGene
Atlanta, GA, US23 -
Ken Wilhelm
Vice President, Global Medical Affairs Lead Hematology at BeiGene
South San Francisco, CA, US25+ -
David Thompson
Vice President, Global Head of Alliance Management at BeiGene
Indianapolis, IN, US25+ -
Wassim Aldairy
VP, Head of Safety Science and Epidemiology at BeiGene
California, United States35 -
22 -
Lusong Luo
SVP, External Innovation at BeiGene
United States32 -
Mark Riedl
Vice President Sales at BeiGene
Scottsdale, AZ, US25 -
Jiang Lin
Vice President, Head of Intellectual Property at BeiGene
Bridgewater, NJ, US31 -
35+
Related Companies
